JCM
MJN

Jacobi Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Jacobi Capital Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-32
Closed -$3K – 870
2017
Q1 		$3K Hold
32
– – ﹤0.01% 619
2016
Q4 		$2K Hold
32
– – ﹤0.01% 577
2016
Q3 		$3K Buy
+32
New +$2.73K ﹤0.01% 628

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Jacobi Capital Management's MJN Position: Q2 2017 in Review

Jacobi Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 32 shares — an estimated $3K sold.

Jacobi Capital Management first reported a position in MJN in Q3 2016 and held it in 3 quarters. The position peaked at $3K in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Jacobi Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Jacobi Capital Management sold 32 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $3K.
  • Jacobi Capital Management first reported a position in Mead Johnson Nutrition Company in Q3 2016 and held it in 3 quarters.
  • Jacobi Capital Management's Mead Johnson Nutrition Company position peaked at $3K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Jacobi Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.